This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Heath, A. Articles by Hultén, B.-A. Search for Related Content PubMed Articles by Heath, A. Articles by Hultén, B.-A. Social Bookmarking                         What's this?

Terbutaline Concentrations in Self-Poisoning: A Case Report

The Poisons Therapy Group, Department of Anaesthesia and Intensive Care, Sahlgren's Hospital, University of Gothenburg, S-413 45 Göteborg, Sweden

B.-Å. Hultén

The Poisons Therapy Group, Department of Anaesthesia and Intensive Care, Sahlgren's Hospital, University of Gothenburg, S-413 45 Göteborg, Sweden

A young female patient was admitted twice within two months, each time after an overdose of 500 mg terbutaline. Clinical features included nausea, tachycardia, tremor, hyperglycemia and hypokalemia. Although plasma concentrations of terbutaline were at least 50 times the normal therapeutic level, after potassium substitution the outcome was uneventful.

Human & Experimental Toxicology, Vol. 6, No. 6, 525-526 (1987)
DOI: 10.1177/096032718700600613


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?